Raymond James & Associates’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $28M | Buy |
441,590
+133,144
| +43% | +$8.43M | 0.02% | 654 |
|
2024
Q2 | $16.4M | Buy |
308,446
+63,206
| +26% | +$3.35M | 0.01% | 874 |
|
2024
Q1 | $20.1M | Buy |
245,240
+107,657
| +78% | +$8.83M | 0.01% | 774 |
|
2023
Q4 | $2.56M | Buy |
137,583
+68,921
| +100% | +$1.28M | ﹤0.01% | 1945 |
|
2023
Q3 | $760K | Buy |
68,662
+150
| +0.2% | +$1.66K | ﹤0.01% | 2625 |
|
2023
Q2 | $1.11M | Buy |
68,512
+22,541
| +49% | +$365K | ﹤0.01% | 2391 |
|
2023
Q1 | $765K | Sell |
45,971
-47,896
| -51% | -$797K | ﹤0.01% | 2620 |
|
2022
Q4 | $882K | Sell |
93,867
-10,861
| -10% | -$102K | ﹤0.01% | 2501 |
|
2022
Q3 | $285K | Sell |
104,728
-8,281
| -7% | -$22.5K | ﹤0.01% | 3196 |
|
2022
Q2 | $327K | Sell |
113,009
-10,742
| -9% | -$31.1K | ﹤0.01% | 3165 |
|
2022
Q1 | $371K | Sell |
123,751
-13,464
| -10% | -$40.4K | ﹤0.01% | 3241 |
|
2021
Q4 | $631K | Sell |
137,215
-114,121
| -45% | -$525K | ﹤0.01% | 2916 |
|
2021
Q3 | $1.58M | Sell |
251,336
-8,085
| -3% | -$50.8K | ﹤0.01% | 2261 |
|
2021
Q2 | $1.55M | Sell |
259,421
-142,309
| -35% | -$852K | ﹤0.01% | 2279 |
|
2021
Q1 | $2.54M | Buy |
401,730
+108,349
| +37% | +$685K | ﹤0.01% | 1850 |
|
2020
Q4 | $1.65M | Sell |
293,381
-86,935
| -23% | -$490K | ﹤0.01% | 2010 |
|
2020
Q3 | $2.21M | Buy |
380,316
+272
| +0.1% | +$1.58K | ﹤0.01% | 1694 |
|
2020
Q2 | $2.74M | Buy |
380,044
+120,986
| +47% | +$872K | ﹤0.01% | 1535 |
|
2020
Q1 | $1.21M | Sell |
259,058
-2,714
| -1% | -$12.7K | ﹤0.01% | 1860 |
|
2019
Q4 | $2.1M | Sell |
261,772
-71,220
| -21% | -$571K | ﹤0.01% | 1796 |
|
2019
Q3 | $2.29M | Sell |
332,992
-81
| -0% | -$557 | ﹤0.01% | 1693 |
|
2019
Q2 | $2.77M | Buy |
333,073
+3,347
| +1% | +$27.8K | ﹤0.01% | 1598 |
|
2019
Q1 | $3.28M | Buy |
329,726
+164,457
| +100% | +$1.63M | 0.01% | 1449 |
|
2018
Q4 | $1.26M | Buy |
165,269
+22,122
| +15% | +$169K | ﹤0.01% | 1953 |
|
2018
Q3 | $2.49M | Buy |
+143,147
| New | +$2.49M | ﹤0.01% | 1683 |
|